Sharif Qais M 4
4 · VISTEON CORP · Filed Mar 3, 2026
Research Summary
AI-generated summary of this filing
Visteon (VC) Senior VP Sharif Qais Receives Stock Awards
What Happened
Sharif Qais, Senior Vice President of Visteon Corp (VC), was granted two equity awards on March 1, 2026: 3,763 performance rights and 2,509 restricted stock units (RSUs). Both awards were reported as derivative grants with an acquisition price of $0.00 (i.e., no cash paid at grant). These are awards (transaction code A), not open-market purchases or sales.
Key Details
- Transaction date: 2026-03-01; Form 4 filed: 2026-03-03 (timely).
- Award amounts: 3,763 performance rights and 2,509 RSUs; reported price $0.00.
- Reported as derivative awards (not immediate common-stock transfers).
- Shares owned after the transaction: not specified in the provided filing details.
- Notable footnotes:
- F1: Each performance right can convert to one share subject to relative shareholder return and return-on-invested-capital (ROIC) performance over a three-year period; payout in stock and subject to tax withholding.
- F2: RSUs vest 33% on each March 15 following the grant until fully vested; each unit converts to one share on vesting and is subject to tax withholding.
- No indication of a 10b5-1 plan, gift, cashless exercise, or late filing in the provided data.
Context
These awards are deferred/contingent equity compensation: performance rights depend on multi-year performance metrics, while RSUs vest over time. Because no cash was exchanged at grant, these do not reflect an immediate purchase or sale of shares; they represent potential future share delivery subject to vesting and performance conditions. For retail investors, such grants are routine executive compensation and do not, by themselves, constitute a direct market buy/sell signal.
Insider Transaction Report
- Award
Performance Rights
[F1]2026-03-01+3,763→ 3,763 totalExp: 2029-02-28→ Common Stock (3,763 underlying) - Award
Restricted Stock Units
[F2]2026-03-01+2,509→ 2,509 totalExp: 2028-03-15→ Common Stock (2,509 underlying)
- 12,054
Common Stock
Footnotes (2)
- [F1]Each performance right represents a contingent right to receive one share of Visteon common stock. The vesting of the performance right is based on relative shareholder return and return on invested capital metrics over a three year performance period and payable in stock, subject to tax withholding.
- [F2]Restricted Stock Units vest to the extent of 33% of the units granted on the following March 15th of each year after the date of grant. Each Restricted Stock Unit will be converted and distributed to me, without payment, in stock upon vesting and based upon the then current market value of a share of Visteon common stock, subject to tax withholding.